Status:
NOT_YET_RECRUITING
Prevalence of Liver Dysfunction in Pediatric Patients With Congenital Heart Disease at Assiut.
Lead Sponsor:
Assiut University
Conditions:
Congenital Heart Disease
Liver Dysfunction
Eligibility:
All Genders
Up to 16 years
Phase:
NA
Brief Summary
Liver dysfunction is a well-documented complication in patients with congenital heart disease (CHD). The mechanisms leading to hepatic dysfunction may be multifactorial. Key risk factors for liver dys...
Detailed Description
Liver dysfunction is a well-documented complication in patients with congenital heart disease (CHD), primarily due to chronic venous congestion, reduced cardiac output, and hypoxemia. The pathophysiol...
Eligibility Criteria
Inclusion
- Confirmed pediatric CHD patients attending Assiut University Children's Hospital.
- Age: from birth up to 16 years old.
Exclusion
- Patients with primary liver disease.
- Recent cardiac surgery (\<3 m) (to exclude acute postoperative liver injury).
- Active systemic infection/sepsis (to avoid confounding liver enzyme elevations).
Key Trial Info
Start Date :
September 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 15 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT07144501
Start Date
September 15 2025
End Date
March 15 2026
Last Update
August 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University Children Hospital.
Asyut, Assiut City, Egypt